Skip to contentN
NEUROONE MEDICAL TECHNOLOGIES Corp
N
NMTCNEUROONE MEDICAL TECHNOLOGIES Corp Q1 2014 · 10-Q
Revenue$165.00$165.00−59.4% vs Q1 2013 Net Income-$4.23K-$4.23KN/M vs Q1 2013 EPS Diluted$0.00$0.00— vs Q1 2013 The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
NEUROONE MEDICAL TECHNOLOGIES Corp · CIK 1500198 · Engraved from SEC EDGAR
Operating Cash Flow-$25N/M Margins · derivedGross margin100.0%±0.0 pt vs Q1 2013
Operating margin-2362.4%−1627.2 pt vs Q1 2013
Net margin-2562.4%−1747.6 pt vs Q1 2013
ended Mar 31, 2014 · filed May 20, 2014 · 50 d after period end